Reason TV: In Praise of Psychedelics

In 1985, despite its widespread reputation as an effective
therapeutic tool, the DEA classified MDMA as a Schedule I drug. The
following year, Rick Doblin founded the Multidisciplinary
Association for Psychedelic Studies (MAPS) with the goal of
developing psychedelics into legal prescription drugs.

Today, MAPS researchers are finding that MDMA can be a
therapeutic aid for people suffering from post-traumatic stress
disorder and that psilocybin, the active ingredient in magic
mushrooms, can be effective at helping addicts. Reason TV talked to
Doblin and other psychedelic researchers at the 2013 Psychedelic
Science Conference in Oakland, California, to learn more.

View this article.